Search - tctmd.com

Displaying 41 - 60 of 639

Sort: Relevancy | Date

Presentation TCT 2025

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Presenter: Kornel Kakonyi

October 26, 2025

Presentation TCT 2025

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

Presenter: Rafal Adam Januszek

October 26, 2025

Presentation TCT 2025

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Presenter: Neal S. Kleiman

October 26, 2025

Presentation TCT 2025

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Aditya Mantha

October 26, 2025

Presentation TCT 2025

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

Presenter: Prakriti Gaba

October 26, 2025

Presentation TCT 2025

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

Presenter: Jennifer Rymer

October 26, 2025

Presentation TCT 2025

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

Presenter: Haseeb Ur Rahman

October 26, 2025

Presentation TCT 2025

TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis

Presenter: Chloe Kharsa

October 26, 2025

Presentation TCT 2025

TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis

Presenter: Mangesh Kritya

October 26, 2025

Presentation TCT 2025

TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions

Presenter: Akshitha Yarrabothula

October 26, 2025

Presentation TCT 2025

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

Presenter: Ankit Hanmandlu

October 26, 2025

Presentation TCT 2025

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

Presenter: Jasvindar Singh

October 26, 2025

Presentation TCT 2025

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Presenter: Scott Harding

October 26, 2025

Presentation TCT 2025

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

Presenter: Fernando Alfonso

October 26, 2025

Presentation TCT 2025

TCT 324: In-Stent Restenosis Rates in CTO-PCI: a Call for a Hybrid Approach

Presenter: Stephane G. Carlier

October 26, 2025

Presentation TCT 2025

TCT 1667: Acute Coronary Syndrome due to Ostial Stent Underexpansion and Acute In-Stent Restenosis

Presenter: Shaan Ali Ahmed

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

Advertisement

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis

TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis

TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results

Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results

TCT 324: In-Stent Restenosis Rates in CTO-PCI: a Call for a Hybrid Approach

TCT 1667: Acute Coronary Syndrome due to Ostial Stent Underexpansion and Acute In-Stent Restenosis

What’s Going to Be Hot at TCT 2025

August 2025 Dispatch for the CV Team

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content